Epilepsy and Cerebellar Ataxia Associated With Anti-Glutamic Acid Decarboxylase Antibodies

Journal of Neurology, Neurosurgery and Psychiatry - United Kingdom
doi 10.1136/jnnp.2006.089268
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Cerebellar Ataxia With Anti–Glutamic Acid Decarboxylase Antibodies

Archives of Neurology
2001English

Cerebellar Ataxia Associated With Glutamic Acid Decarboxylase Autoantibody (Anti GAD)

Scholars Journal of Medical Case Reports
2020English

Diabetes Mellitus and Ataxia With Anti-Glutamic Acid Decarboxylase Antibodies

Endocrine Abstracts
2016English

Effects of Anti-Glutamic Acid Decarboxylase Antibodies Associated With Neurological Diseases

Annals of Neurology
Neurology
2007English

Clinical Management of Epilepsy With Glutamic Acid Decarboxylase Antibody Positivity: The Interplay Between Immunotherapy and Anti-Epileptic Drugs

Frontiers in Neurology
Neurology
2018English

Anti–Glutamic Acid Decarboxylase Antibodies in the Serum and Cerebrospinal Fluid of Patients With Stiff-Person Syndrome

Archives of Neurology
2004English

Paraneoplastic Cerebellar Degeneration Associated With Anti-Itpr1 Antibodies

Neurology: Neuroimmunology and NeuroInflammation
Neurology
2017English

Absence of Glutamic Acid Decarboxylase Antibodies in Pima Indian Children With Diabetes Mellitus

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1999English

Persisting Antibodies to Glutamic Acid Decarboxylase in Type 1 (Insulin-Dependent) Diabetes Mellitus Are Not Associated With Neuropathy

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy